Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure

Affiliations

• ¹ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China; Peking-Tsinghua Center for Life Sciences, Tsinghua University, Beijing, China.
• ² Changping Laboratory, Beijing, China.
• ³ Beijing Ditan Hospital, Capital Medical University, Beijing, China.
• ⁴ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
• ⁵ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
• ⁶ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; College of Future Technology, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China.
• ⁷ Changping Laboratory, Beijing, China; Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.
• ⁸ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China; School of Life Sciences, Peking University, Beijing 100871, China; Changping Laboratory, Beijing, China. Electronic address: yunlongcao@pku.edu.cn.